Business
Press Release Jul 26 2024
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated July 26, 2024, titled "Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 U.S. FDA Approves LEQSELVI (deuruxolitinib)".
About this update from Sun Pharmaceutical Industries Limited
[{"type":"text","content":" Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated July 26, 2024, titled \"Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 U.S. FDA Approves LEQSELVI (deuruxolitinib)\". View Attachment","length":431,"tagName":"div"}]